ArticleScience translational medicine2023

Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma.

Cristina Mastini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.